These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21347962)

  • 21. Randomized trial on the effectiveness of long-and short-term psychodynamic psychotherapy and solution-focused therapy on psychiatric symptoms during a 3-year follow-up.
    Knekt P; Lindfors O; Härkänen T; Välikoski M; Virtala E; Laaksonen MA; Marttunen M; Kaipainen M; Renlund C;
    Psychol Med; 2008 May; 38(5):689-703. PubMed ID: 18005493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in the Rorschach and MMPI-2 after electroconvulsive therapy (ECT): a collaborative assessment case study.
    Keddy P; Erdberg P
    J Pers Assess; 2010 Jul; 92(4):279-95. PubMed ID: 20552503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Personality disorder traits and self-reported target problems in a treatment-seeking sample.
    Huband N; Evans C; Duggan C; Khan O
    Clin Psychol Psychother; 2014; 21(2):132-9. PubMed ID: 23225377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Operationalizing the psychodynamic diagnostic manual: a preliminary study of the psychodiagnostic chart.
    Gordon RM; Stoffey RW
    Bull Menninger Clin; 2014; 78(1):1-15. PubMed ID: 24552426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utility of the MMPI-2 in assessing gender dysphoric patients.
    Miach PP; Berah EF; Butcher JN; Rouse S
    J Pers Assess; 2000 Oct; 75(2):268-79. PubMed ID: 11020144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The mental functioning axis of the psychodynamic diagnostic manual: an adolescent case study.
    Porcerelli JH; Cogan R; Bambery M
    J Pers Assess; 2011 Mar; 93(2):177-84. PubMed ID: 21347966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of changing from the MMPI to the MMPI-2 on profile configurations.
    Humphrey DH; Dahlstrom WG
    J Pers Assess; 1995 Jun; 64(3):428-39. PubMed ID: 7760254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An examination of three sets of MMPI-2 personality disorder scales.
    Jones A
    J Pers Disord; 2005 Aug; 19(4):370-85. PubMed ID: 16178680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Client attachment to therapist: Relation to client personality and symptomatology, and their contributions to the therapeutic alliance.
    Bachelor A; Meunier G; Laverdiére O; Gamache D
    Psychotherapy (Chic); 2010 Dec; 47(4):454-68. PubMed ID: 21198235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of simulating borderline personality disorder on the MMPI-2: a costs-benefits model employing base rates.
    Sivec HJ; Hilsenroth MJ; Lynn SJ
    J Pers Assess; 1995 Apr; 64(2):295-311. PubMed ID: 7722855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intermittent psychotherapy: an alternative to continuous long-term treatment for patients with personality disorders.
    Paris J
    J Psychiatr Pract; 2007 May; 13(3):153-8. PubMed ID: 17522558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical utility of the MMPI-2 Restructured Clinical (RC) Scales in therapeutic assessment: a case study.
    Wygant DB; Fleming KP
    J Pers Assess; 2008 Mar; 90(2):110-8. PubMed ID: 18444103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of response frequency on the Rorschach constellation indices and on their validity with diagnostic and MMPI-2 criteria.
    Meyer GJ
    J Pers Assess; 1993 Feb; 60(1):153-80. PubMed ID: 8433265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incremental validity of the MMPI-2 PSY-5 scales in assessing self-reported personality disorder criteria.
    Wygant DB; Sellbom M; Graham JR; Schenk PW
    Assessment; 2006 Jun; 13(2):178-86. PubMed ID: 16672732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rorschach Comprehensive System data for a sample of 52 older adult nonpatients from the United States.
    Pertchik K; Shaffer TW; Erdberg P; Margolin DI
    J Pers Assess; 2007; 89 Suppl 1():S166-73. PubMed ID: 18039157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The MMPI-2 as a predictor of symptom change following treatment for posttraumatic stress disorder.
    Forbes D; Creamer M; Allen N; Elliott P; McHugh T; Debenham P; Hopwood M
    J Pers Assess; 2002 Oct; 79(2):321-36. PubMed ID: 12425394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative validity of MMPI-2 and MCMI-II personality disorder classifications.
    Wise EA
    J Pers Assess; 1996 Jun; 66(3):569-82. PubMed ID: 8667148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The North Carolina Dissociation Index: a measure of dissociation using items from the MMPI-2.
    Mann BJ
    J Pers Assess; 1995 Apr; 64(2):349-59. PubMed ID: 7722859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Psychological examinations of the personality of patients with cardiac syndrome X].
    Chodorowski Z; Majkowicz M; Waldman W; Ciećwierz D; Sein Anand J; Wnuk K; Ciechanowicz R
    Przegl Lek; 2002; 59(4-5):281-5. PubMed ID: 12183989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Examination of the impact of ethnicity on the Minnesota Multiphasic Personality Inventory-2 (MMPI-2) Fake Bad Scale.
    Dean AC; Boone KB; Kim MS; Curiel AR; Martin DJ; Victor TL; Zeller MA; Lang YK
    Clin Neuropsychol; 2008 Dec; 22(6):1054-60. PubMed ID: 18609316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.